Beyond bispecific antibodies
There is no doubt that bispecific antibodies represent a major step forward in the development of effective therapies to treat different diseases.
Complex indications as well as emerging treats such as infectious diseases require novel approaches to multi-targeting.
We are actively developing our antibody light chain approach to create bispecific antibody mixtures in a simple and reliable manner.
If you share our vision and want to work with us, please contact us.
